IRB Archives - Advarra

Q&A with Advarra’s Client Experience Partner Brian Boggs

As a member of Advarra’s client experience team, Brian Boggs plays a pivotal role in helping research clients navigate complex

Q&A with Advarra’s Associate Director of Client Services Anna Carnevale

Over the past 14 years, Anna Carnevale, associate director of client services at Advarra, has seen her team grow from

Q&A with Advarra’s new Senior Vice President, FDA Regulatory Advisor, Jan Hewett

Clinical research drives medical progress. Advarra ensures participant safety and ethical standards through expert IRB oversight for life-changing therapies.

Navigating Local Considerations When Developing sIRB Reliance Policies

Implementing an sIRB process requires addressing unique local considerations, from consent requirements to cultural nuances, ensuring a streamlined yet ethical review process.

IBC vs. IRB: What’s the Difference?

Gene therapy research requires both IRB and IBC oversight—while IRBs protect participants, IBCs ensure community and environmental safety with local site-specific reviews.

Beginner’s Guide to Single IRB Mandates

As clinical trial efficiencies grow, understanding single IRB mandates becomes crucial for sites and sponsors navigating ethical review processes.

Your Guide to sIRB Mandates

In the past few years, new regulations and policies have been announced and implemented to address the challenges of conducting clinical trials involving multiple research sites. Chief among these requirements is the use of a designated sIRB for multisite research.